Close menu




May 31st, 2022 | 13:22 CEST

Chip shares turn - Infineon, Nvidia and BrainChip in the next upward wave

  • AI
  • chips
  • Innovations
Photo credits: pixabay.com

Despite the chip shortage that has persisted since last year and the associated booming business of manufacturers, they came under a lot of pressure on the stock market in recent weeks in the wake of the weak overall market. The prospects for the industry remain positive, the semiconductor shortage will continue until at least 2023, and the order books of the producers are full to bursting. Now, many companies are starting to bottom out. In the long term, Nvidia and AMD are likely to be quoted significantly higher. A newcomer is also making a run for the top again after a lengthy correction phase.

time to read: 3 minutes | Author: Stefan Feulner
ISIN: INFINEON TECH.AG NA O.N. | DE0006231004 , NVIDIA CORP. DL-_001 | US67066G1040 , BRAINCHIP HOLDINGS LTD | AU000000BRN8

Table of contents:


    BrainChip with trend-confirming correction

    A correction in the range of 75% tends to confirm the trend, especially for young innovative companies such as the IP company BrainChip. After a price explosion in the last final quarter, which drove the share of the Australian Company from EUR 0.30 to EUR 1.67, a stronger correction then set in. For example, in the middle of last month, the share price gap was closed at EUR 0.62. The relative strength indicator already recorded a buy signal, and the trend-following indicator MACD is close to it. The next price target should be closing a price gap again, this time at the level of EUR 0.98.

    BrainChip is the world's first commercial manufacturer of neuromorphic AI chips and, with "Akida", offers, according to the Company's management, "the most efficient AI solution ever produced." The Akida processor is extremely low-power and high-performance, supporting the growth of edge AI technology through the use of neuromorphic architecture, a type of artificial intelligence inspired by the biology of the human brain. With each transaction, Akida thereby learns autonomously, making it suitable for modern edge devices. In addition to autonomous driving, areas of application include robotics, medical diagnostics and security technology.

    The recently rising share prices are underpinned by outstanding news. The inclusion of BrainChip in ARM's partner program is equivalent to an accolade. According to the announcement, the British company's partner program is an ecosystem of hardware and software specialists designed to enable developers to create the next generation of AI solutions. Mohamed Awad, vice president of IoT and embedded at ARM, had this to say: "As part of ARM's AI Partner Program, BrainChip will enable developers to address the need for high-performance and ultra-low-power edge AI inference, enabling new innovation opportunities."

    Infineon AG - Positive signals

    Infineon Technologies AG, headquartered in Neubiberg, Germany, offers semiconductor and system solutions with a focus on energy efficiency, mobility and security. In the process, Germany's largest chip group by far is growing rapidly, and the demand for semiconductors remains unabatedly high. Now Infineon wants to increase its production capacities more quickly. "In the future, we will decide on a major investment every two or three years," new Chief Production Officer Rutger Wijburg told the Handelsblatt newspaper. He said the group built a new factory every four to five years in the past. "It cannot be ruled out that we will also push ahead with large projects in parallel at some point," the manager said. So far, the Munich-based company has built one plant after another.

    Wijburg went on to say, "Twelve-month delivery times are now common for tools, and 18 months and longer are not uncommon either." The manager brushed aside concerns that Infineon might invest too much: "Structural overcapacity is not to be expected. After all, there is hardly any innovation left without semiconductors." After developing a double bottom at EUR 25.23, the share was able to leave the support zone to the upside. A striking buy signal would occur by exceeding the resistance area at EUR 33.26.

    Nvidia - The search for the bottom

    Industry leader Nvidia has lost more than 55% since mid-November last year. From USD 346.57, it went back to USD 155.69. So far, this support area has been held three times, and most recently, the stock was up around 5% under high volume. The share is currently clearly oversold, and the trend-following indicator MACD could also turn soon, which should at least point to a stronger countermovement.

    The Company announced on May 25 the figures for its first quarter of the fiscal year 2022/2023, showing the continued strong demand for technology for data centers and graphics cards, which increased the sales of the US by 46% compared to the same quarter last year to currently USD 8.29 billion.

    "We delivered record results in data center and gaming against the backdrop of a challenging macroeconomic environment," said Jensen Huang, founder and CEO of Nvidia. In contrast, profit fell to USD 1.61 billion from USD 1.91 billion in the year-ago period. The reason for the profit drop is the failed acquisition of ARM, which is why Nvidia had to pay USD 1.35 billion to SoftBank as stipulated in the contract.


    After the substantial price losses in recent weeks, shares in the chip industry could be bottoming out. While Nvidia could perform after the numbers, Infineon wants to expand its manufacturing capacities further. The young IP company BrainChip could also start the next wave upward after closing a gap.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Armin Schulz on March 19th, 2025 | 07:00 CET

    SAP, MiMedia, Alibaba – Why Cloud Services are the Gold mines of the Future

    • Digitization
    • Technology
    • AI
    • cloud
    • Software

    Microsoft once again set a milestone in the second quarter of 2025 with a turnover of USD 69.6 billion. Driven by cloud services, which increased by 21%, and artificial intelligence (AI), which grew by 175%, the tech giant exceeded analysts' expectations. Azure and cloud services alone grew by 31%, while the AI business generated USD 13 billion. But the race has only just begun: Microsoft plans to spend USD 80 billion on AI data centers, which is just a fraction of the global investments that are expected to catapult the cloud market to USD 2.4 trillion by 2030. Who is footing the bill for the hunger for AI? And who stands to benefit most? The answers lie in the cloud.

    Read

    Commented by Fabian Lorenz on March 18th, 2025 | 07:35 CET

    D-Wave and naoo stocks escalate! Will the rally continue? HelloFresh after a price slide with a 100% chance?

    • Digitization
    • AI
    • computing

    100% in one week! D-Wave's stock made a spectacular comeback last week. Despite stagnating revenues and high losses, investors pushed the stock to its old record level of USD 10. Can the rally continue after such a strong outlook? naoo's stock has also rebounded. The newcomer to the German stock market combines the opportunities of social media and AI. The sell-off was likely exaggerated, and a takeover caused the price to jump. And what about HelloFresh? After a disappointing outlook, the stock fell sharply. Is a 100% price gain possible now?

    Read

    Commented by Armin Schulz on March 18th, 2025 | 07:00 CET

    Bayer, Vidac Pharma, BioNTech – Making money with biotech and pharmaceutical innovations

    • Biotechnology
    • Biotech
    • Pharma
    • Innovations

    More and more investors are betting on companies that are leaving traditional therapeutic paths to rethink cancer, chronic inflammation, or nutritional issues. While some corporations struggle with their balance sheets due to mountains of debt and patent expirations, others are quietly developing technologies that crack the metabolic code of diseases. Whether anti-aging tests from saliva samples, mRNA-based cancer cocktails, or active ingredients that overcome the blood-brain barrier – the stock market rewards those who combine research success with strategic risk-taking. But which companies have what it takes to develop the blockbusters of tomorrow? Let's take a closer look at three companies.

    Read